Harmony Biosciences Holdings, Inc. (HRMY) Q1 2026 Earnings Call Transcript

Harmony Biosciences Holdings, Inc. (HRMY) Q1 Earnings and Revenues Miss Estimates

Harmony Biosciences Reports Q1 Financial Results and Confirms 2026 Net Revenue Guidance of Over $1 Billion; Reinforces 2026 Strategic Priorities

Looking for a Growth Stock? 3 Reasons Why Harmony Biosciences (HRMY) is a Solid Choice

HRMY or ARGX: Which Is the Better Value Stock Right Now?

Wall Street Analysts Think Harmony Biosciences (HRMY) Could Surge 34.81%: Read This Before Placing a Bet

Harmony Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026

Harmony Biosciences to Present Open-Label Extension Data From Phase 3 ARGUS Trial at the 2026 American Academy of Neurology Annual Meeting

Harmony Biosciences Eyes $1B WAKIX Runway, Teases 2026 Pipeline Catalysts at Needham Conference

Harmony Biosciences Holdings, Inc. (HRMY) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

Harmony Biosciences Appoints Glenn Reicin as Chief Financial Officer

Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its Board

Harmony Biosciences to Participate in 25th Annual Needham Virtual Healthcare Conference

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Average Recommendation of “Hold” from Brokerages

Harmony Biosciences to Participate in Upcoming Investor Conferences

Harmony Biosciences Holdings, Inc. (HRMY) Q4 2025 Earnings Call Transcript

Harmony Biosciences Holdings, Inc. (HRMY) Q4 Earnings Miss Estimates

Harmony Biosciences Reports Strong 2025 Financial Results and Reiterates 2026 Net Revenue Guidance of Over $1 Billion

4 Value Stocks to Buy Now Amid AI-Driven Market Volatility

Top 5 Bargain P/B Stocks Investors Should Watch Now

Earnings Preview: Harmony Biosciences Holdings, Inc. (HRMY) Q4 Earnings Expected to Decline

Harmony Biosciences Receives U.S. Food and Drug Administration Approval for WAKIX® (pitolisant) for the Treatment of Cataplexy in Pediatric Narcolepsy

3 Reasons Why Growth Investors Shouldn't Overlook Harmony Biosciences (HRMY)

Wall Street Analysts Believe Harmony Biosciences (HRMY) Could Rally 26.95%: Here's is How to Trade

HRMY vs. ARGX: Which Stock Is the Better Value Option?

Is Harmony Biosciences (HRMY) Stock Undervalued Right Now?

Harmony Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

New York State Common Retirement Fund Acquires 29,501 Shares of Harmony Biosciences Holdings, Inc. $HRMY

5 Value Picks Amid AI-Driven Tech Sell-Off & U.S.-Iran Tensions

5 Low Price-to-Book Stocks That Are Worth Watching in February

Harmony Biosciences Chief Financial Officer Sells Shares Again After Previous Exit From Company Equity

Harmony Biosciences' CFO Sells All of His Insider Shares, Worth $752,800

Harmony Biosciences' CFO Sells All of Her Insider Shares, Worth $752,800

4 Value Stocks to Consider as Tech Volatility Weighs on Wall Street

4 GARP Stocks With Attractive PEG Ratios and Strong Growth Outlooks

Is Harmony Biosciences (HRMY) a Solid Growth Stock? 3 Reasons to Think "Yes"

How Harmony Biosciences Can Prove Its Skeptics Wrong

Harmony Biosciences' Sales and Profits Have Soared. Why Hasn't Its Stock Followed?

HRMY or ARGX: Which Is the Better Value Stock Right Now?

I Was Shocked to Find This Value-Priced Biotech Growth Stock

Should Value Investors Buy Harmony Biosciences (HRMY) Stock?

Campbell & CO Investment Adviser LLC Has $796,000 Holdings in Harmony Biosciences Holdings, Inc. $HRMY

Buy These 5 Price-to-Book Value Stocks for Gains in 2026

Harmony Biosciences Holdings, Inc. (HRMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Harmony Biosciences (HRMY) is an Incredible Growth Stock: 3 Reasons Why

Harmony Biosciences Guides to Over $1 Billion in WAKIX® Revenue in 2026; Advancing Robust Late-Stage Pipeline With Potential for Long-term Value Creation

HRMY vs. LQDA: Which Stock Is the Better Value Option?

Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?

CX Institutional Has $6.35 Million Stock Holdings in Harmony Biosciences Holdings, Inc. $HRMY

Harmony Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference